Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuxi Yi
Observed names:
Y. Yi,
Yangke Yi,
Yi, Yangke,
Yu-xi Yi
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center,
Shanghai Clinical Research Center
ORCID:
0000-0002-6831-6920
Observed ORCID:
0000-0002-6831-6920
OpenAlex ID:
A5089184924
Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2020
·
Yuxi Yi
, Lijun Shen
, et al.
·
Clinical Cancer Research
·
211
The gut microbiota as a booster for radiotherapy: novel insights into radio-protection and radiation injury
2023
·
Yuxi Yi
, Weiqing Lu
, et al.
·
Experimental Hematology and Oncology
·
77
PDF
Immune Score Predicts Outcomes of Gastric Cancer Patients Treated with Adjuvant Chemoradiotherapy
2021
·
Wei Zou
, Meng-long Zhou
, et al.
·
Journal of Oncology
·
12
PDF
The Gut Microbiome Profile Predicts the Severe Acute Toxicities in Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemoradiation
2021
·
Y. Yi
, L. Shen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
4
PDF
Gut Microbiome Predicts Neoadjuvant Chemoradiotherapy Response in Locally Advanced Rectal Cancer Patients
2020
·
L. Shen
, Y. Yi
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Resmetirom for noncirrhotic metabolic dysfunction–associated steatohepatitis with liver fibrosis: establishing a value-based price in China, the UK, France, and Germany
2026
·
Andong Li
, Meiyu Wu
, et al.
·
Figshare
First-line treatments for metastatic non-small-cell lung cancer with sugemalimab plus chemotherapy: a China-based cost-effectiveness analysis
2026
·
Zhang, Zixuan
, Meng, Kehui
, et al.
·
Figshare
Supplementary methods and Table S1 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
Figure S4 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
Figure S5 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
PDF
Figure S3 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
PDF
Figure S1 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
Figure S2 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
PDF
Figure S4 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
PDF
Figure S3 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
Figure S5 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
Figure S2 from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
Data from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
PDF
Data from Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study
2023
·
Yuxi Yi
, Lijun Shen
, et al.
80MO Gut microbiome analysis for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer patients
2020
·
Y. Yi
, L. Shen
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
20
Citation count:
305
H-index:
4
I10-index:
3
Year
Topic
Type